Literature DB >> 24049265

Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Dheeraj Gupta1, Ritesh Agarwal, Ashutosh Nath Aggarwal, V N Maturu, Sahajal Dhooria, K T Prasad, Inderpaul S Sehgal, Lakshmikant B Yenge, Aditya Jindal, Navneet Singh, A G Ghoshal, G C Khilnani, J K Samaria, S N Gaur, D Behera.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a major public health problem in India. Although several International guidelines for diagnosis and management of COPD are available, yet there are lot of gaps in recognition and management of COPD in India due to vast differences in availability and affordability of healthcare facilities across the country. The Indian Chest Society (ICS) and the National College of Chest Physicians (NCCP) of India have joined hands to come out with these evidence-based guidelines to help the physicians at all levels of healthcare to diagnose and manage COPD in a scientific manner. Besides the International literature, the Indian studies were specifically analyzed to arrive at simple and practical recommendations. The evidence is presented under these five headings: (a) definitions, epidemiology, and disease burden; (b) disease assessment and diagnosis; (c) pharmacologic management of stable COPD; (d) management of acute exacerbations; and (e) nonpharmacologic and preventive measures. The modified grade system was used for classifying the quality of evidence as 1, 2, 3, or usual practice point (UPP). The strength of recommendation was graded as A or B depending upon the level of evidence.

Entities:  

Keywords:  Asthma; chronic bronchitis; chronic obstructive pulmonary disease; emphysema; guidelines

Year:  2013        PMID: 24049265      PMCID: PMC3775210          DOI: 10.4103/0970-2113.116248

Source DB:  PubMed          Journal:  Lung India        ISSN: 0970-2113


  406 in total

1.  FORCED EXPIRATORY TIME: A SIMPLE TEST FOR AIRWAYS OBSTRUCTION.

Authors:  S LAL; A D FERGUSON; E J CAMPBELL
Journal:  Br Med J       Date:  1964-03-28

2.  [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].

Authors:  Jin-ping Zheng; Jian Kang; Bai-qiang Cai; Xin Zhou; Zhao-long Cao; Chun-xue Bai; Nan-shan Zhong
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2006-06

Review 3.  Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies.

Authors:  Yoon K Loke; Rodrigo Cavallazzi; Sonal Singh
Journal:  Thorax       Date:  2011-05-20       Impact factor: 9.139

4.  Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease.

Authors:  Naoya Tanabe; Shigeo Muro; Toyohiro Hirai; Tsuyoshi Oguma; Kunihiko Terada; Satoshi Marumo; Daisuke Kinose; Emiko Ogawa; Yuma Hoshino; Michiaki Mishima
Journal:  Am J Respir Crit Care Med       Date:  2011-03-11       Impact factor: 21.405

5.  Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.

Authors:  D P Spence; J G Hay; J Carter; M G Pearson; P M Calverley
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

6.  One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.

Authors:  J B Oostenbrink; M P M H Rutten-van Mölken; M J Al; J A Van Noord; W Vincken
Journal:  Eur Respir J       Date:  2004-02       Impact factor: 16.671

7.  Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?

Authors:  K C Chang; C C Leung; W W Yew; T Y Lau; W M Leung; C M Tam; H C Lam; P S Tse; M Y Wong; S N Lee; K I Wat; Y H Ma
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

8.  Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate.

Authors:  Dorota Górecka; Michal Bednarek; Adam Nowiński; Elzbieta Puścińska; Anna Goljan-Geremek; Jan Zieliński
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

Review 9.  COPD exacerbations: definitions and classifications.

Authors:  S Burge; J A Wedzicha
Journal:  Eur Respir J Suppl       Date:  2003-06

10.  Peak expiratory flow rate underestimates severity of airflow obstruction in acute asthma.

Authors:  Inseon S Choi; Youngil I Koh; Ho Lim
Journal:  Korean J Intern Med       Date:  2002-09       Impact factor: 2.884

View more
  28 in total

1.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

2.  Type 2 innate lymphoid cells participate in IL-33-stimulated Th2-associated immune response in chronic obstructive pulmonary disease.

Authors:  Min Jiang; Simin Tao; Shaohua Zhang; Jing Wang; Fengbo Zhang; Fengsen Li; Jianbing Ding
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

3.  Indian guidelines for asthma: Adherence is the key.

Authors:  Parvaiz A Koul; Dharmesh Patel
Journal:  Lung India       Date:  2015-04

Review 4.  Enhancing indoor air quality -The air filter advantage.

Authors:  Vannan Kandi Vijayan; Haralappa Paramesh; Sundeep Santosh Salvi; Alpa Anil Kumar Dalal
Journal:  Lung India       Date:  2015 Sep-Oct

5.  Real-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatment.

Authors:  Vladimir Koblizek; Ladislav Pecen; Jaromir Zatloukal; Jana Kocianova; Marek Plutinsky; Vitezslav Kolek; Barbora Novotna; Eva Kocova; Sarka Pracharova; Ales Tichopad
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

6.  Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India.

Authors:  Vinay Mahishale; Arati Mahishale; Bhagyashri Patil; Avuthu Sindhuri; Ajith Eti
Journal:  Niger Med J       Date:  2015 Mar-Apr

Review 7.  When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines.

Authors:  Johanna Laue; Eirik Reierth; Hasse Melbye
Journal:  NPJ Prim Care Respir Med       Date:  2015-02-19       Impact factor: 2.871

8.  Chronic obstructive pulmonary disease: Indian guidelines and the road ahead.

Authors:  Parvaiz A Koul
Journal:  Lung India       Date:  2013-07

Review 9.  Diagnosing COPD: advances in training and practice - a systematic review.

Authors:  Vladimir Koblizek; Barbora Novotna; Zuzana Zbozinkova; Karel Hejduk
Journal:  Adv Med Educ Pract       Date:  2016-04-04

Review 10.  Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.

Authors:  Marc Miravitlles; Anthony D'Urzo; Dave Singh; Vladimir Koblizek
Journal:  Respir Res       Date:  2016-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.